Using next-gen AI to design drugs against complex disorders
Gero has raised €1.9M across 1 funding round from 1 investor, most recently a Series A round in Aug 2020. Based in Russia; founded 2012; active in AI. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-08-04 | Series A | €1.9M |
| Bulba Ventures |
| View deal → |
